Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

Abstract Background Remifentanil is widely used for ultrasound-guided percutaneous radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC). We determined whether dexmedetomidine could be an alternative to remifentanil for RFA of HCC under general anesthesia with sevoflurane. Methods We...

Full description

Bibliographic Details
Main Authors: Jingru Pan, Xianlong Li, Ye He, Chaojun Jian, Hui-xin Chen, Ziqing Hei, Shaoli Zhou
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Trials
Subjects:
Catheter ablation
Dexmedetomidine
Pain measurement
Online Access:http://link.springer.com/article/10.1186/s13063-018-3010-z

Internet

http://link.springer.com/article/10.1186/s13063-018-3010-z

Similar Items